This molecular heterogeneity is apparent in a recent study that reported differential expression of programmed death-ligand 1 (PD-L1) protein within the different tumor areas (core, periphery, and healthy tissue) in the same GBM patient [7]. Here, CD274 is linked to glioblastoma.